Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
combination drug |
| gptkbp:activeIngredient |
gptkb:saxagliptin
metformin hydrochloride |
| gptkbp:approvalYear |
2010
|
| gptkbp:ATCCode |
A10BD09
|
| gptkbp:contraindication |
severe renal impairment
metabolic acidosis |
| gptkbp:form |
extended-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kombiglyze XR
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:marketedIn |
gptkb:European_Union
gptkb:United_States |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
gastrointestinal upset |
| gptkbp:usedFor |
gptkb:type_2_diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:AstraZeneca_US
|
| gptkbp:bfsLayer |
6
|